1. Home
  2. SPXC vs LCTX Comparison

SPXC vs LCTX Comparison

Compare SPXC & LCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SPX Technologies Inc.

SPXC

SPX Technologies Inc.

HOLD

Current Price

$181.37

Market Cap

9.7B

Sector

Industrials

ML Signal

HOLD

Logo Lineage Cell Therapeutics Inc.

LCTX

Lineage Cell Therapeutics Inc.

HOLD

Current Price

$1.05

Market Cap

255.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPXC
LCTX
Founded
1912
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.7B
255.4M
IPO Year
1994
1996

Fundamental Metrics

Financial Performance
Metric
SPXC
LCTX
Price
$181.37
$1.05
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
4
Target Price
$245.56
$6.25
AVG Volume (30 Days)
353.4K
941.4K
Earning Date
04-30-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
18.08
N/A
EPS
2.73
N/A
Revenue
$2,265,100,000.00
$14,556,000.00
Revenue This Year
$16.07
$109.40
Revenue Next Year
$7.68
N/A
P/E Ratio
$65.82
N/A
Revenue Growth
14.17
53.24
52 Week Low
$176.21
$1.00
52 Week High
$251.08
$2.09

Technical Indicators

Market Signals
Indicator
SPXC
LCTX
Relative Strength Index (RSI) 33.51 38.23
Support Level N/A N/A
Resistance Level $225.70 $1.18
Average True Range (ATR) 5.52 0.05
MACD -1.12 -0.00
Stochastic Oscillator 18.40 0.00

Price Performance

Historical Comparison
SPXC
LCTX

About SPXC SPX Technologies Inc.

SPX Technologies Inc supplies engineered heating, ventilation, and air conditioning, or HVAC, products, as well as detection and measurement technologies and power equipment. The company operates through two reportable segments. The HVAC segment which generates the majority of the revenue for the company, designs, manufactures, installs, and services cooling products, as well as heating and ventilation products. The Detection and Measurement technologies segment designs, manufactures, and installs underground pipe and cable locators and inspection equipment, bus-fare collection systems, and others. Geographically, the company has its operations in the United States, Canada, China, the United Kingdom, and Others. It derives maximum revenue from United States.

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline currently includes: OpRegen, OPC1, ReSonance, ILT1, RND1, PNC1, and LCT-CON. Its programs are based on its proprietary, in-house, cell-based manufacturing platform, which it call AlloSCOPE (Allogeneic, Scalable, Consistent, Off-the-shelf, Pluripotent Cell Engineering), and supported by its associated development, formulation, manufacturing, and delivery capabilities. The AlloSCOPE platform is a proprietary differentiation and production modality from which, a single, well-characterized pluripotent cell line can create a stable current Good Manufacturing Practice, master cell bank.

Share on Social Networks: